Targeted surface engineered magnetic nanoformulation for hepatocellular carcinoma: A preclinical approach to improve in vivo safety and bioavailability
Fields of Study & Subjects
Nanoparticle-Based Drug Delivery
Nanoplatforms for cancer theranostics
Hepatocellular Carcinoma Treatment and Prognosis
Publication details
- Journal / source
- Journal of Drug Delivery Science and Technology
- Publisher
- Elsevier BV
- Volume
- 121
- Pages
- 108337–108337
- Publication date
- 15 April 2026
- Language
- EN